Strong partnerships
drive financial results

We specialize in Corporate Finance
and Capital Markets

Corporate Finance

Arctica Finance's Corporate Finance department provides various services related to financial markets to small and medium sized enterprises, large cap enterprises, institutions, public entities and individuals, both domestically and internationally.

More
→

Capital Markets

Arctica Finance's Capital Markets focus on servicing domestic and overseas institutional investors with Icelandic related exposure.

More
→

News

View all news
30.10.2025
Oculis completes a USD 110 million share offering

Today, Thursday, October 30, 2025, Oculis Holding AG (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology, announced the completion of a share offering of approximately ISK 13.6 billion (USD 110 million).

More
→
11.9.2025
ORF Genetics secures EUR 5 million in equity financing

ORF Genetics has completed an EUR 5 million equity financing round, with participation from both new and existing shareholders. ORF produces specialized proteins in barley plants, which are a key component in the production of cultivated meat. Cultivated meat production has advanced rapidly over the past decade, and ORF has developed its MESOKINE line of growth factors, tailored to the needs of the cultivated meat producers. ORF‘s growth factors are trusted by leading players in the cultivated meat market.

More
→
13.6.2025
Arctica Finance managed Kaldalón ’s bond issuance

Arctica Finance hf. managed the sale of a new bond series called KALD 201228 issued by Kaldalón hf. Kaldalón sold ISK 1,500m nominal at a yield of 8.35%.

More
→